Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bonavida

Showing results (241-250 of 276) with videos related to

Pageof 28
Sort By:
International Journal of Oncology|June 6, 1998
Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA/ionomycinS Mori, A Jewett, M Cavalcanti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosisA R Jazirehi, C P Ng, X H Gan, et al.
Annals of the New York Academy of Sciences|November 25, 1994
Prolonged asymptomatic states in HIV-seropositive persons with fewer than 50 CD4+ T cells per MM3. Psychoneuroimmunologic findingsG F Solomon, D Benton, J O Harker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1983
Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cellsS C Wright, M L Weitzen, R Kahle, et al.
Oncogene|July 28, 2009
Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP inductionS Baritaki, A Chapman, K Yeung, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 5, 2002
Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosisA Zisman, C P Ng, A J Pantuck, et al.
Journal of Clinical Immunology|September 1, 1994
Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivativeX H Gan, J P Robin, J M Huerta, et al.
International Journal of Oncology|May 6, 2011
Sensitization of AIDS related non-Hodgkin's B lymphoma cell lines to cytotoxic drugs toxins by interferon-gammaA Demidem, Z Salahuddin, T Lam, et al.
Immunobiology|December 1, 1987
Lysis of natural killer-sensitive and -resistant tumor cells by natural killer cytotoxic factors (NKCF)-containing liposomesR C Roozemond, D C Urli, S C Wright, et al.
Anticancer Research|November 1, 1991
Cytotoxic activity of synthetic aza alkyl lysophospholipids against drug sensitive and drug resistant human tumor cell linesH Morimoto, C Broquet, P Principe, et al.
Pageof 28

Showing results (241-250 of 276) with videos related to

Sort By:
Pageof 28
International Journal of Oncology|June 6, 1998
Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA/ionomycinS Mori, A Jewett, M Cavalcanti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosisA R Jazirehi, C P Ng, X H Gan, et al.
Annals of the New York Academy of Sciences|November 25, 1994
Prolonged asymptomatic states in HIV-seropositive persons with fewer than 50 CD4+ T cells per MM3. Psychoneuroimmunologic findingsG F Solomon, D Benton, J O Harker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1983
Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cellsS C Wright, M L Weitzen, R Kahle, et al.
Oncogene|July 28, 2009
Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP inductionS Baritaki, A Chapman, K Yeung, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 5, 2002
Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosisA Zisman, C P Ng, A J Pantuck, et al.
Journal of Clinical Immunology|September 1, 1994
Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivativeX H Gan, J P Robin, J M Huerta, et al.
International Journal of Oncology|May 6, 2011
Sensitization of AIDS related non-Hodgkin's B lymphoma cell lines to cytotoxic drugs toxins by interferon-gammaA Demidem, Z Salahuddin, T Lam, et al.
Immunobiology|December 1, 1987
Lysis of natural killer-sensitive and -resistant tumor cells by natural killer cytotoxic factors (NKCF)-containing liposomesR C Roozemond, D C Urli, S C Wright, et al.
Anticancer Research|November 1, 1991
Cytotoxic activity of synthetic aza alkyl lysophospholipids against drug sensitive and drug resistant human tumor cell linesH Morimoto, C Broquet, P Principe, et al.
Pageof 28